Genomictree Inc
KOSDAQ:228760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genomictree Inc
KOSDAQ:228760
|
KR |
|
J
|
Jiangxi Copper Co Ltd
XMUN:JIX
|
CN |
|
G
|
Groep Brussel Lambert NV
F:EAI
|
BE |
|
CJ Corp
KRX:001040
|
KR |
|
A
|
Aristocrat Leisure Ltd
F:AC8
|
AU |
|
P
|
Pentair PLC
F:PNT
|
UK |
|
E
|
Equifax Inc
F:EFX
|
US |
|
T
|
Toray Industries Inc
F:6HK
|
JP |
|
Clariane SE
PAR:CLARI
|
FR |
|
O
|
OneJoon Co Ltd
KOSDAQ:382840
|
KR |
|
Wilh Wilhelmsen Holding ASA
F:WML2
|
NO |
|
W
|
WIIK PCL
SET:WIIK
|
TH |
|
Wheels Up Experience Inc
NYSE:UP
|
US |
|
H
|
Halliburton Co
SWB:HAL
|
US |
|
A
|
Acom Co Ltd
F:AK5
|
JP |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
|
Intiland Development Tbk PT
IDX:DILD
|
ID |
|
Republic Airways Holdings Inc
F:M2A0
|
US |
|
Sanrio Co Ltd
F:SJ8
|
JP |
|
Adavale Resources Ltd
ASX:ADD
|
AU |
Shareholder Yield
Current shareholder yield for Genomictree Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Genomictree Inc
| Average Annual Return | 14% |
| Standard Deviation of Annual Returns | 76.62% |
| Max Drawdown | -72% |
| Market Capitalization | 243B KRW |
| Shares Outstanding | 24 860 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Genomictree Inc's latest stock split occurred on Sep 14, 2018
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
The adjusted shares began trading on Sep 14, 2018. This was stock split number 2 in Genomictree Inc's history, following the previous one in Nov 9, 2017.